Phreesia Corp (PHR) - Kompaniya qiymatining sof foydaga nisbati

Phreesia Corp (PHR) korporativ emblemasi va logotipi

Phreesia, Inc. (PHR) AQSh klinikalarining raqamli administratori sifatida nuqsonsiz obro'ga ega. Emitentning P/E koeffitsiyenti bozor kutganlarini aks ettiradi va joriy ko'rsatkich 76.30 ni tashkil etadi. Daromadlar to'lovlar va ro'yxatdan o'tishni avtomatlashtirish uchun bulutli obunalar asosida shakllantirilgan. Dasturiy ta'minotning sog'liqni saqlash infratuzilmasiga integratsiyasi back-office xizmatlarining kompaniya ekotizimiga kritik bog'liqligini yaratib, biznesning barqaror o'sishini ta'minlaydi.

Phreesia Corp (PHR) - P/E multiplikatori 04.07.2022dan 12.11.2026gacha

Phreesia, Inc. kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahlili:Phreesia, Inc.
Phreesia, Inc. original mahsuloti

Ushbu ko'rsatkich aktivning fundamental haddan tashqari sotib olingan holatini baholash uchun aksiyaning bozor qiymatini oldingi davrdagi sof foyda bilan solishtirgan holda investitsiyalarning qoplanish muddatini aniqlaydi. Hisoblangan narx-foyda koeffitsiyentini tahlil qilish orqali investor tibbiy to'lovlarni avtomatlashtirish va sog'liqni saqlash gigantlari bilan tuzilgan reklama shartnomalari daromadni qanchalik samarali real foydaga aylantirishini baholashi mumkin, bu esa Phreesia, Inc. (PHR) kapitalining barqarorligini tasdiqlaydi.

Muhim raqobatchilar

veeva.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori DOCS|HQY (HealthEquity Inc) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Waystar Inc. WAY|Kompaniya qiymatining sof foydaga nisbati CRVL|Privia Health Group - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati huronconsultinggroup.com|CERT: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Omnicell Inc (OMCL)|Narxning foydaga nisbati GoodRx Corp|Schrodinger Corp (SDGR) - Biznesning o‘zini qoplash muddati|P/E multiplikatori OMDA|Biznesning o‘zini qoplash muddati evolenthealth.com|P/E multiplikatori HSTM (HealthStream)|P/E multiplikatori Definitive Healthcare Corp DH|CCSI: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AGL (Agilon Health Corp)|ABSI: P/E multiplikatori|SY - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati National Research Corporation|Narx-foyda multiplikatori SPOK (Spok Holdings Inc)|P/E multiplikatori OPRX|Narx-foyda koeffitsiyenti TruBridge Corp TBRG|Simulations Plus, Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Sophia Genetics (SOPH)|HCAT - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CCLD|RSSS: P/E multiplikatori|DLH Holdings - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati OneMedNet Corp|SCNX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori HCTI|Biznesning o‘zini qoplash muddati ispecimen.com|Bullfrog AI - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati WORX (SCWorx Inc)|MSPR: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ICCT (iCoreConnect Inc.)|TRxADE HEALTH (MEDS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Orgenesis Inc|RCM (R1 RCM, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Sharecare Inc SHCR|P/E multiplikatori STRM|syrahealth.com - Narx-foyda multiplikatori|Narxning foydaga nisbati Apollo Medical Holdings, Inc. AMEH|MODN (Model N Inc) - Kapitalizatsiyaning sof foydaga nisbati|NextGen - P/E multiplikatori